Richard Garr - curasan AG Insider

CUR -- Germany Stock  

EUR 0.96  0.012  1.26%

  CEO
Mr. I. Richard Garr J.D. is Director of the Company. He is no longer Chief Financial Officer of the Company. effective May 18 2015. Mr. Garr was previously an attorney with Beli Weil Jacobs the BG Companies and Circle Management Companies. Mr. Garr is a graduate of Drew University and the Columbus School of Law The Catholic University of America . Additionally he was a founder and current Board Trustee of the First Star Foundation a childrens charity focused on abused childrens issues a founder of The Starlight Foundation Mid Atlantic chapter which focuses on helping seriously ill children and is a past Honorary Chairman of the Brain Tumor Society.
Age: 61  CEO Since 2016      
49 6027 40 900 51  http://www.curasan.de

Richard Garr Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (13.09) % which means that it has lost $13.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (42.32) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 265 K in total debt with debt to equity ratio (D/E) of 2.6 implying the company greatly relies on financing operations through barroing. curasan AG has Current Ratio of 2.1 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 1 records

CEO Since

Liam CondonBayer Aktiengesellschaft
N/A

Entity Summary

curasan AG develops, produces, and markets biomaterials and medical devices for bone and tissue regeneration worldwide. The company was founded in 1988 and is based in Kleinostheim, Germany. curasan AG operates under Biotechnology classification in Germany and traded on Frankfurt Stock Exchange. It employs 30 people.curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Lindigstrasse 4 and employs 30 people.

curasan AG Leadership Team

William Oldaker, Independent Director
David Castaneda, IR Contact
Stanley Westreich, Independent Director
Karl Johe, Chairman of the Board, Chief Scientific Officer
Scott Ogilvie, Independent Director
Catherine Sohn, Director
Richard Garr, President CEO, General Counsel, Director
Richard Daly, President CEO
Sandford Smith, Director
Jonathan Jones, CFO

Stock Performance Indicators

Current Sentiment - CUR

curasan AG Investor Sentiment
Macroaxis portfolio users are unresponsive in their opinion about investing in curasan AG. What is your take regarding investing in curasan AG? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for curasan AG and Fielmann AG. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">